Netcare

Data Analytics Platform Will Optimize Clinical Operations By End Of 2024

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

28 Jan 25

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-1.1%

You can edit this narrative until May 12 6:00 AM. Then, changes will post as Updates.

Author's Valuation

R16.428.2% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

Fair value Decreased 3.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 1.25%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 3.01%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

R16.42

8.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.82%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

16.99%

Calculation

R2.12b

Earnings '28

13.29x

PE Ratio '28

R28.22b

Market Cap '28

R28.22b

Market Cap '28

1.11b

No. shares '28

R25.31

Share Price '28

R25.31 Share Price '28

Discounted to 2025 @ 17.42% p.a.

R15.64

Fair Value '25